HIMS Hims & Hers Health, Inc.

16.02USD-6.04%Mkt Cap: 3.76B USDP/E: —

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of I…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap3.76B USD
Enterprise Value4.60B USD
Revenue (TTM)2.87B USD
Gross Profit1.73B USD
Net Income (TTM)128.37M USD
Revenue/Share12.46 USD
Last Price16.02 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees2.4K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)39.65
PEG1.80
EV/EBITDA-60.95
EV/Revenue1.60
P/S1.31
P/B10.57
EPS (TTM)-0.83 USD
EPS (Forward)0.40 USD
52W Range
13.748% of range40.99
52W High40.99 USD
52W Low13.74 USD
Profitability
Gross Margin73.84%
Oper. Margin-6.39%
EBITDA Margin-2.63%
Profit Margin5.47%
ROE23.73%
ROA5.96%
ROIC9.74%
ROCE6.03%
Growth
Revenue Growth48.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF300.01M USD
CapEx (TTM)242.59M USD
FCF Margin19.98%
FCF Yield15.26%
Net Debt848.53M USD
Net Debt/EBITDA-11.23
Net Debt/FCF1.48
Balance Sheet
Debt/Equity2.07
Current Ratio0.92
Quick Ratio0.79
Book Value/Sh1.52 USD
Cash/Share3.04 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.7 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)28.31 USD
Upside (mean)+76.7%
Target Range23.00 USD – 40.00 USD
23.00+76.7% to mean40.00
# Analysts13
Ownership
Shares Out.226.03M
Float214.86M
Insiders5.09%
Institutions71.64%
Short Interest
Short Ratio5.2d
Short % Float26.47%
Short % Out.22.04%
Shares Short51.66M
Short (prev mo.)54.77M
Technical
SMA 5027.00 (-40.7%)
SMA 20026.55 (-39.7%)
Beta2.50
S&P 52W Chg12.00%
Avg Vol (30d)13.79M
Avg Vol (10d)22.20M
Technical Indicators
RSI (14)27.0
MACD-3.0319
MACD Signal-2.2611
MACD Hist.-0.7708
BB Upper32.40 USD
BB Middle23.45 USD
BB Lower14.51 USD
BB Width76.29%
ATR (14)1.925 USD
Vol Ratio (20d)0.88x

About Hims & Hers Health (NYSE: HIMS)

›

Hims & Hers Health (NYSE: HIMS) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 2,442 employees.

The shares were at 16.02 USD on 19 November 2026, down 56.7% over 52 weeks. Its 52-week range is 13.74 USD to 40.99 USD: the price is 60.9% below the high and 16.6% above the low.

Its market capitalisation is 3.76B USD.

Hims & Hers Health reports return on equity of 23.7%, an operating margin of -6.4% and revenue up 48.6% year over year.

Its debt exceeds its cash by 848.53M USD, a debt-to-equity ratio of 2.07. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 13 analysts cover the stock, with an average rating of Hold; their mean price target of 28.31 USD is 76.7% above the current price. The next earnings report is expected on 1 March 2027.